Breast Cancer Treatment Studies

Breast cancer is not a single disease but a collection of molecularly distinct subtypes, each defined by characteristic patterns of gene expression and hormone receptor activity that shape how tumors grow and respond to treatment. Researchers in this area work to identify prognostic markers — measurable biological signals that predict whether a patient's cancer is likely to recur or respond to a given therapy — with the goal of moving beyond one-size-fits-all protocols toward treatment matched to tumor biology. Neoadjuvant therapy, where chemotherapy or hormone-targeting drugs are given before surgery, has become a particularly active area because it allows scientists to observe how a tumor changes under treatment in real time, generating data that can refine both clinical guidelines and molecular models. Central open questions include why tumors of the same apparent subtype still vary widely in their response to radiotherapy or systemic treatment, and how expression-based signatures can be made robust enough to guide decisions reliably across diverse patient populations.

Works

118,585

Total citations

2,006,870

Keywords

Gene ExpressionBreast TumoursTreatment ResponseMolecular SubtypesPrognostic MarkersNeoadjuvant Therapy